ArticleJAMA health forum2026
Financial Effects of an Out-of-Pocket Cap in Traditional Medicare.
Article in JAMA health forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Traditional Medicare (TM) exposes beneficiaries to substantial financial risk because, unlike Medicare Advantage (MA), there is no out-of-pocket (OOP) maximum for medical spending. Policymakers have proposed introducing an OOP cap, but its fiscal and behavioral effects are uncertain. Objective: To estimate the financial impacts of introducing OOP spending caps of $3000, $5000, or $10 000 annually in TM on beneficiary costs, enrollment patterns, and Centers for Medicare & Medicaid Services expenditures between 2026 and 2034. Design, Setting, and Participants: This economic evaluation using principles of microsimulation analysis projected enrollment, spending, and health care use outcomes under baseline (no OOP cap) and 3 alternative cap scenarios using publicly available national Medicare and insurance data from 2020 to 2024 with projections through 2034. The model incorporated elasticity-based behavioral responses, including beneficiary switching between TM and MA, changes in service use, and increases to MA benchmarks and spending. Sensitivity analyses varied model assumptions probabilistically. Exposure: Introduction of annual OOP caps for Parts A and B in TM at $3000, $5000, or $10 000. Main Outcomes and Measures: Projected changes in beneficiary enrollment by coverage type, mean annual beneficiary OOP and premium spending, and annual Medicare expenditures. Results: Between 2026 and 2034, a $3000 OOP cap was projected to reduce mean annual beneficiary expenditures by $1568, compared with $1138 under a $5000 cap and $707 under a $10 000 cap. Corresponding increases in annual Medicare spending were estimated at $96 billion (90% simulation uncertainty interval [SUI], $80-$114 billion), $70 billion (90% SUI, $55-$85 billion), and $39 billion (90% SUI, $29-$50 billion), respectively. OOP caps, especially at lower thresholds, would substantially shift beneficiaries from MA to TM. Conclusions and Relevance: Results of this study suggest that implementing an OOP spending cap in TM would provide meaningful financial protection for beneficiaries but impose substantial fiscal costs on Medicare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.